Clinical Performance of Short Fiber Reinforced Resin Modified Glass Ionomer Restorations in Cervical Carious Teeth (1y Randomized Clinical Trial)
NCT ID: NCT06185881
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-03-01
2023-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Bioceramic vs High Viscosity GIC for Cervical Restorations of Geriatric Patients
NCT05624008
Evaluation of Glass Ionomer With Advanced Glass Hybrid Technology Versus Resin Modified Glass Ionomer in Adult Patients With Carious Cervical Lesions After One Year
NCT05617703
Clinical Evaluation of Giomer Based Injectable Resin Composite Versus Resin Modified Glass Ionomer in Class V Carious Cavities Over 18-months.
NCT05389163
Resin Modified Glass Ionomer Versus Self-Adhesive Resin Composite Restorative Systems
NCT06543680
The Effectiveness RMGI and Giomer, Individually and Combined Anterior Cervical Caries
NCT06901453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Short fiber reinforced resin modified glass ionomer restorations (GC Europe)
restoration of cervical carious teeth
restoration of carious cervical lesions by glass ionomer
Resin modified glass ionomer restoration. (Fugi II LC, GC Europe)
restoration of cervical carious teeth
restoration of carious cervical lesions by glass ionomer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
restoration of cervical carious teeth
restoration of carious cervical lesions by glass ionomer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with normal occlusion
* Vital teeth with carious cervical lesion with asymptomatic vital pulp.
* Teeth with no or minimum mobility.
* Teeth with normal occlusion.
* Teeth with surrounding healthy gingiva and supporting-structures.
Exclusion Criteria
* Presence of abnormal oral, medical or mental conditions.
* Patients with severe medical diseases.
* Patients with xerostomia
* Patients with parafunctional habits.
* Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
* Severe periodontal problems.
* Non carious cervical lesions.
18 Years
38 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rawda Hesham Abd ElAziz
Lecturer, Conservative dentistry department, Faculty of Dentistry, Cairo University.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBD 5/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.